Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing

Y Abe, T Kachi, T Kato, Y Arahata, T Yamada, Y Washimi, K Iwai, K Ito, N Yanagisawa, G Sobue, Y Abe, T Kachi, T Kato, Y Arahata, T Yamada, Y Washimi, K Iwai, K Ito, N Yanagisawa, G Sobue

Abstract

Objective: The purpose of this study was to analyse changes in regional cerebral blood flow (rCBF) in Parkinson's disease (PD) without dementia.

Methods: Twenty eight non-demented patients with PD and 17 age matched normal subjects underwent single photon emission computed tomography with N-isopropyl-p-[(123)I]iodoamphetamine to measure rCBF. The statistical parametric mapping 96 programme was used for statistical analysis.

Results: The PD patients showed significantly reduced rCBF in the bilateral occipital and posterior parietal cortices (p<0.01, corrected for multiple comparison p<0.05), when compared with the control subjects. There was a strong positive correlation between the score of Raven's coloured progressive matrices (RCPM) and the rCBF in the right visual association area (p<0.01, corrected for multiple comparison p<0.05) among the PD patients.

Conclusions: This study showed occipital and posterior parietal hypoperfusion in PD patients without dementia. Furthermore, it was demonstrated that occipital hypoperfusion is likely to underlie impairment of visual cognition according to the RCPM test, which is not related to motor impairment.

References

    1. Brain. 2000 Feb;123 ( Pt 2):340-52
    1. J Nucl Med. 1999 Oct;40(10):1583-9
    1. Brain. 1966 Mar;89(1):53-82
    1. Cortex. 1970 Mar;6(1):19-46
    1. Brain. 1970;93(3):525-46
    1. J Psychiatr Res. 1975 Nov;12(3):189-98
    1. Res Publ Assoc Res Nerv Ment Dis. 1976;55:115-49
    1. Arch Neurol. 1984 May;41(5):485-90
    1. Neurology. 1985 Aug;35(8):1127-34
    1. Neurology. 1985 Oct;35(10):1399-405
    1. Brain Cogn. 1982 Jan;1(1):71-83
    1. Brain. 1987 Dec;110 ( Pt 6):1675-98
    1. Trends Neurosci. 1990 Jul;13(7):266-71
    1. J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):787-92
    1. Mol Chem Neuropathol. 1991 Jun;14(3):153-97
    1. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
    1. Brain. 1992 Apr;115 ( Pt 2):521-37
    1. Arch Neurol. 1992 Dec;49(12):1262-8
    1. Arch Neurol. 1993 Feb;50(2):140-8
    1. Eur J Nucl Med. 1993 Apr;20(4):339-44
    1. Dementia. 1993 Nov-Dec;4(6):334-41
    1. Neurobiol Aging. 1994 May-Jun;15(3):329-35
    1. Vision Res. 1994 Oct;34(19):2629-38
    1. J Nucl Med. 1994 Dec;35(12):2019-30
    1. Brain Res Brain Res Rev. 1995 Jan;20(1):91-127
    1. Brain. 1995 Jun;118 ( Pt 3):771-8
    1. Acta Neurol Scand. 1995 Sep;92(3):235-41
    1. Neurology. 1997 Jun;48(6):1566-71
    1. J Neurol Sci. 1998;156(1):83-8
    1. Brain. 1998 Apr;121 ( Pt 4):611-31
    1. Brain. 1998 Dec;121 ( Pt 12):2229-38
    1. Neurology. 1999 Feb;52(3):541-6
    1. Brain. 1999 Feb;122 ( Pt 2):303-13

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner